Medicenna Therapeutics Corp.
MDNA.TO
Price:
$2.37
Market Cap:
$182.01M
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a ...[Read more]
Industry
Biotechnology
IPO Date
2017-03-08
Stock Exchange
TSX
Ticker
MDNA.TO
PE Ratio
[-6.24]
ROE
[-149.65%]
Current Ratio
[9.43]
Dividend Yield
[0%]
Enterprise Value
[146.38M]
Dividend History
The ROE as of November 2024 (TTM) for Medicenna Therapeutics Corp. (MDNA.TO) is -149.65%
According to Medicenna Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -149.65%. This represents a change of 83.43% compared to the average of -81.59% of the last 4 quarters.
Medicenna Therapeutics Corp. (MDNA.TO) Historical ROE (quarterly & annually)
How has MDNA.TO ROE performed in the past?
The mean historical ROE of Medicenna Therapeutics Corp. over the last ten years is 295.63%. The current -149.65% ROE has changed -150.62% with respect to the historical average. Over the past ten years (40 quarters), MDNA.TO's ROE was at its highest in in the December 2015 quarter at 0%. The ROE was at its lowest in in the September 2019 quarter at -983.91%.
Average
295.63%
Median
-84.06%
Minimum
-490.58%
Maximum
4.32%
Medicenna Therapeutics Corp. (MDNA.TO) ROE by Quarter and Year
Discovering the peaks and valleys of Medicenna Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.41%
Maximum Annual ROE = 4.32%
Minimum Annual Increase = -9450.51%
Minimum Annual ROE = -490.58%
| Year | ROE | Change |
|---|---|---|
| 2024 | -490.58% | -9450.51% |
| 2023 | 5.25% | -104.83% |
| 2022 | -108.69% | 141.29% |
| 2021 | -45.05% | 95.97% |
| 2020 | -22.99% | -87.23% |
| 2019 | -179.93% | -47.90% |
| 2018 | -345.33% | 201.23% |
| 2017 | -114.64% | 92.91% |
| 2016 | -59.43% | -101.38% |
| 2015 | 4.32% | 1.41% |
Medicenna Therapeutics Corp. (MDNA.TO) Average ROE
How has MDNA.TO ROE performed in the past?
The current ROE of Medicenna Therapeutics Corp. (MDNA.TO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-198.01%
5-year avg
-132.41%
10-year avg
295.63%
Medicenna Therapeutics Corp. (MDNA.TO) ROE vs. Peers
How is MDNA.TO’s ROE compared to its peers?
Medicenna Therapeutics Corp.’s ROE is greater than Aptose Biosciences Inc. (-5683.22%), greater than IMV Inc. (-495.17%), greater than BELLUS Health Inc. (-11.40%), greater than Oncolytics Biotech Inc. (-114.55%), less than Helix BioPharma Corp. (42.60%),
| Company | ROE | Market cap |
|---|---|---|
| -5683.22% | $9.96M | |
| -495.17% | $13.12M | |
| -11.40% | $2.47B | |
| -114.55% | $123.18M | |
| 42.60% | $37.26M |
Build a custom stock screener for Medicenna Therapeutics Corp. (MDNA.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medicenna Therapeutics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Medicenna Therapeutics Corp. (MDNA.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Medicenna Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Medicenna Therapeutics Corp.'s ROE?
How is the ROE calculated for Medicenna Therapeutics Corp. (MDNA.TO)?
What is the highest ROE for Medicenna Therapeutics Corp. (MDNA.TO)?
What is the 3-year average ROE for Medicenna Therapeutics Corp. (MDNA.TO)?
What is the 5-year average ROE for Medicenna Therapeutics Corp. (MDNA.TO)?
How does the current ROE for Medicenna Therapeutics Corp. (MDNA.TO) compare to its historical average?